Ionis Pharmaceuticals ($IONS) delivered exactly what retail dreams about: official FDA approval for a rare brain disorder treatment. The market rewarded shareholders with an immediate 11.34% flush.
Flip side: BrenX ($BRNX) surged 26.79% on absolute silence, and iSpecimen ($ISPC) jumped 21.43% on a standard 8-K agreement filing. Across 4,191 historical setups of low-float stocks gapping up over 20% on zero news, the base rate fades into the red 68% of the time with a median intraday bleed of 8.50%.
Smart money dumps real news into late bids while retail finances weekend risk on phantom liquidity.
68% statistical fade into two days of market holiday. That is the trap.